The Calmer Co. Secures $25 Million Global Kava Distribution Deal

Exclusive Distribution Deal Unlocks New Revenue Stream

The Calmer Co. International Limited (ASX:CCO) has secured a significant multi-year distribution agreement with a multinational ingredients company, granting exclusive rights to distribute its kava extract ingredients across Australia, New Zealand, the United States, Canada, and ASEAN markets. The deal requires the distributor to meet minimum purchase commitments totalling approximately A$25 million over three years, including A$5.5 million in the first year, marking a substantial contracted revenue stream for the company’s botanical ingredients business.

Strategic Expansion Beyond Consumer Products

This agreement represents a strategic pivot for The Calmer Co., expanding its footprint beyond branded consumer products into high-margin wholesale botanical ingredient sales. CEO Zane Yoshida emphasised the deal’s validation of global demand for their kava extracts and its alignment with the company’s integrated Pacific kava business model, which spans sourcing, manufacturing, and global commercialisation.

Notably, the agreement complements the company’s recent supply deals and manufacturing partnerships, including the long-term supply agreement for premium noble kava from Papua New Guinea and Vanuatu valued at around A$8.65 million annually, and the manufacturing partnership with Kaiming Agro Processing to scale advanced CO2 extraction capabilities in Fiji. These linkages secure both upstream raw material supply and downstream distribution channels, reinforcing the company’s vertically integrated strategy.

Co-Branding and Commercial Protections Enhance Partnership

The distribution deal includes co-branding provisions that allow the distributor’s ingredient brand to appear on The Calmer Co.’s finished products, strengthening the commercial relationship. It also incorporates standard commercial safeguards such as retention of title and annual price review mechanisms, providing the company with enhanced payment security and pricing flexibility.

The distributor, part of a multinational group specialising in plant-derived ingredients, supplies botanical and nutritional raw materials to dietary supplements and complementary medicine markets across more than 60 countries. This scale underscores the potential reach and impact of the new distribution channel for The Calmer Co.’s kava extracts.

Manufacturing Capacity to Support Growth

To meet anticipated volumes under the agreement, The Calmer Co. will rely on existing specialist extraction partners in Australia and India, alongside the upcoming supercritical CO2 extraction facility in Fiji commissioned under its partnership with Kaiming Agro Processing. This manufacturing capacity expansion is critical to fulfilling the distributor’s escalating purchase commitments over the three-year term.

Integrated Pacific Supply Chain Drives Value

This deal ties directly into The Calmer Co.’s broader strategy to monetise its Pacific kava supply chain. By connecting premium raw material sourcing from Fiji, Papua New Guinea, and Vanuatu with a committed global distribution channel, the company is building a diversified, high-value ingredients sales platform that reduces reliance on direct wholesale sales alone.

Quality assurance remains central, with mutual inspection rights and product quality warranties embedded in the agreement, supporting customer confidence and the company’s reputation as a supplier of premium Pacific kava extracts.